9 /100
LOW RISK
Score updated Jul 14, 2026

CAH — Cardinal Health, Inc. Dilution Risk Tracker

Track CAH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CAH — Get alerts when the score changes →

As of July 14, 2026, Cardinal Health, Inc. (CAH) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. Cardinal Health, Inc. has a market capitalization of $46.09B, 235.32M shares outstanding, 1434 institutional holders tracked. Key dilution vectors include approximately 337 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
19
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CAH.
🔔 Track CAH — Get forecast alerts →

💹 Market Data

Market Cap$46.09B
Shares Outstanding235.32M
Float233.73M
Cash$2.98B
Debt$2.85B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.6% shares (2026Q1 vs prior)
1434 institutional holders · 249.46M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 30.58M shares
#2 BlackRock, Inc. 28.49M shares
#3 MORGAN STANLEY 15.31M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.07M
Days to Cover2.7
% of Float3.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Feb 18, 2026
4 INSIDER TRANSACTION Feb 10, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CAH Shareholders

Cardinal Health, Inc. (CAH) has a DilutionScore of 9/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for CAH shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CAH in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CAH alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CAH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CAH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CAH
📊 CAH FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CAH Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.